Dementia is associated with medial temporal atrophy even after accounting for neuropathologies

Davis C Woodworth1,2, Nasim Sheikh-Bahaei3, Kiana A Scambray1,2

  • 1Department of Neurology, University of California, Irvine, CA, USA.

Brain Communications
|March 30, 2022
PubMed

Insights

Brain atrophy is strongly linked to dementia status, particularly in medial temporal lobe structures. This association persists even after accounting for common neuropathologies like Alzheimer's disease.

Area of Science:

  • Neuroimaging
  • Neuropathology
  • Dementia Research

Background:

  • Brain atrophy is a known indicator of neurodegenerative diseases and dementia.
  • The independent contribution of dementia to brain atrophy, separate from specific neuropathologies, remains unclear.

Purpose of the Study:

  • To investigate the pattern of brain atrophy associated with dementia, while controlling for common neuropathologies.
  • To determine if dementia status independently correlates with atrophy in specific brain regions.

Main Methods:

  • Utilized 3D-T1w MRI and autopsy data from National Alzheimer's Coordinating Center and Alzheimer's Disease Neuroimaging Initiative cohorts.
  • Employed voxel-based morphometry and multiple linear regression to analyze atrophy patterns, adjusting for neuropathologies and demographics.
  • Examined the mediating effect of medial temporal lobe volumes on the relationship between pathology and cognition.

Main Results:

  • Dementia status showed strong associations with reduced volumes of the hippocampus, amygdala, and parahippocampus.
  • Dementia status explained more unique variance in atrophy of these structures (~8%) than most neuropathologies, except hippocampal sclerosis in the hippocampus (10%).
  • Medial temporal lobe volumes partially mediated the link between Alzheimer's disease pathology and cognitive function.

Conclusions:

  • Medial temporal lobe atrophy is predominantly associated with the clinical status of dementia, rather than solely with Alzheimer's disease or other neuropathologies.
  • This finding highlights the clinical relevance of medial temporal lobe atrophy in dementia.
  • Hippocampal sclerosis represents a notable exception, showing a strong direct association with hippocampal atrophy.

Related Concept Videos

Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
199
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
705
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
274